Home › Funds › Royce & Associates › ARCT
Royce & Associates position in ARCT
ARCTURUS THERAPEUTICS HLDGS · Health Care
Latest position (Q3 2024)155.80K sh
Reported value held$3.62M
Portfolio Weight0.03%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 79.84K | $3.81M | New |
| Q4 2021 | 79.84K | $2.96M | Hold |
| Q1 2022 | 79.84K | $2.15M | Hold |
| Q2 2022 | 79.84K | $1.26M | Hold |
| Q3 2022 | 79.84K | $1.18M | Hold |
| Q4 2022 | 79.84K | $1.35K | Hold |
| Q1 2023 | 79.84K | $1.91K | Hold |
| Q2 2023 | 129.84K | $3.72M | Add |
| Q3 2023 | 129.84K | $3.32M | Hold |
| Q4 2023 | 129.84K | $4.09M | Hold |
| Q1 2024 | 131.72K | $4.45M | Add |
| Q2 2024 | 131.72K | $3.21M | Hold |
| Q3 2024 | 155.80K | $3.62M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ARCT
- ARK Invest 2.90M sh · $19.50M · Q2 2026
- BlackRock Inc 2.61M sh · $17.57M · Q2 2026
- Vanguard Group 2.09M sh · $12.81M · Q4 2025
- Two Sigma Investments 1.09M sh · $7.33M · Q2 2026
- Geode Capital Management 693.66K sh · $4.66M · Q2 2026
- AQR Capital Management 675.01K sh · $4.54M · Q2 2026
- UBS Group AG 490.63K sh · $3.30M · Q2 2026
- D. E. Shaw & Co 392.36K sh · $2.64M · Q2 2026
- Millennium Management 337.00K sh · $2.26M · Q2 2026
- Goldman Sachs Group 309.86K sh · $2.08M · Q2 2026
- Charles Schwab Investment Management 231.63K sh · $1.56M · Q2 2026
- Point72 Asset Management 231.58K sh · $1.56M · Q2 2026